SCHEMBL7860302

SCHEMBL7860302

CC(=O)OCc1cc2c(cc1COC(C)=O)CC(NC(=O)C(F)(F)F)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.39
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CA12 O43570 3/20 0.35
CA7 P43166 3/20 0.35
CA14 Q9ULX7 3/20 0.35
KDM4E B2RXH2 2/20 0.34
CA9 Q16790 2/20 0.34
CYP3A4 P08684 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 2/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865550 0.86 KDM4E (0.41) LMNAGAACA1CA2CA12
SCHEMBL4124063 0.83 CA1 (0.39) LMNAGAACA1CA2CA12
SCHEMBL4607791 0.78 APOB (0.36) LMNAGAACA1CA2CA12
SCHEMBL4607688 0.72 MAPT (0.45) CA1CA2CA12CA7CA14
SCHEMBL4607263 0.71 CA1 (0.43) CA1CA2CA12CA7CA14
SCHEMBL7690123 0.71 CA1 (0.43) LMNAGAACA1CA2CA12
SCHEMBL7248144 0.71 CA1 (0.43) LMNAGAACA1CA2CA12
SCHEMBL2283276 0.70 MAPT (0.50) LMNAKDM4EMTNR1AMTNR1B
SCHEMBL3441786 0.69 CA1 (0.43) LMNAGAACA1CA2CA12
SCHEMBL3534959 0.68 POLB (0.40) KDM4EALDH1A1HTTMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807101-B1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS UPJOHN CO (US) 2001-06-13 EP disclosed
US-6084130-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2000-07-04 US disclosed
US-5936000-A 2-aminoindans as selective dopamine D3 ligands PHARMACIA & UPJOHN COMPANY (US) 1999-08-10 US disclosed
EP-0807101-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1997-11-19 EP disclosed
WO-1996023760-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1996-08-08 WO disclosed